190 related articles for article (PubMed ID: 7214860)
21. [The effect of kavinton on bronchial tonus in bronchial asthma patients].
Karashurov SE
Eksp Klin Farmakol; 1994; 57(6):35-6. PubMed ID: 7756957
[TBL] [Abstract][Full Text] [Related]
22. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
Turrisi E; D'Alise R; Mea A; Vitagliano A
Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
[No Abstract] [Full Text] [Related]
23. [Vincamine in patients with cerebral vascular insufficiency].
Novis SP; Moretto M; Fenelon SB; Barbosa CS; da Graça Torres J
Arq Neuropsiquiatr; 1975 Mar; 33(1):25-32. PubMed ID: 1164205
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
Ambrozi L; Bruck J; Tschabitscher H
Nervenarzt; 1982 Mar; 53(3):141-3. PubMed ID: 7078689
[No Abstract] [Full Text] [Related]
25. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
Fidetzis K; Brosteano R; Keller P
Med Welt; 1976 Jul; 27(29):1412-4. PubMed ID: 785150
[No Abstract] [Full Text] [Related]
26. [About cavinton therapy of the patients with brain vascular diseases].
Nikitina VV; Pravdina AN; Zapatrina OV
Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
[No Abstract] [Full Text] [Related]
27. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
28. Open-labeled phase III clinical trials with vinpocetine in Japan.
Ebi O
Ther Hung; 1985; 33(1):41-9. PubMed ID: 3915913
[No Abstract] [Full Text] [Related]
29. [Electrophysiological variations induced by (-) eburnamonine in patients with chronic cerebrovascular insufficiency].
Facciolla D; Mozzillo A; Rossi A; Ruocco A; Serra C
Riv Neurol; 1980; 50(6):383-405. PubMed ID: 7291876
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effect of vincamine teprosilate on behavioural performances of patients affected with chronic cerebrovascular disease.
Casale R; Giorgi I; Guarnaschelli C
Int J Clin Pharmacol Res; 1984; 4(4):313-9. PubMed ID: 6500778
[TBL] [Abstract][Full Text] [Related]
31. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
Lanfranchi M; Magnani G; Sinforiani E; Casali R
Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
[TBL] [Abstract][Full Text] [Related]
32. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
Kauchtschischvili G; Nappi G; Bono G
Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
[No Abstract] [Full Text] [Related]
33. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
Sov Med; 1983; (10):111-3. PubMed ID: 6658534
[No Abstract] [Full Text] [Related]
34. [Clinical and electrophysiologic changes produced by (--) eburnamonine in acute and post-acute stages of head injuries].
Facciolla D; Ruocco A; Rossi A; Serra C; Bufalino L; Cavrini P
Riv Neurol; 1983; 53(1):15-33. PubMed ID: 6857109
[TBL] [Abstract][Full Text] [Related]
35. [The therapeutic action of kavinton electrophoresis in cerebrovascular diseases].
Musaev AV; Balakishieva FK; Nabiev NN
Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):19-22. PubMed ID: 9771139
[No Abstract] [Full Text] [Related]
36. [Prospects of using cavinton for treating Ménière's disease].
Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
[No Abstract] [Full Text] [Related]
37. [Serial angiographic and clinical evaluation of the effects of vicamine in cerebrovascular insufficiency].
Elefante R; Graziussi G; Baliano G; Granata F
Minerva Med; 1975 Sep; 66(64):3322-36. PubMed ID: 1178130
[No Abstract] [Full Text] [Related]
38. CBF changes after (-)eburnamonine infusion in patients with cerebrovascular insufficiency.
Gossetti B; Ventura M; Damiano M; Bait C; Zaccaria A
Eur Neurol; 1978; 17 Suppl 1():171-2. PubMed ID: 753632
[TBL] [Abstract][Full Text] [Related]
39. [Vincamine in the therapy of cerebral vascular diseases in the aged].
De Candia O; Bartolucci E; Mancinella A; Baghiris D
Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
[No Abstract] [Full Text] [Related]
40. [The intravenous laser therapy of circulatory encephalopathy].
Shapovalov VM; Podvigin AV; Opekunova GT; Storokha AA
Voen Med Zh; 1996 Apr; 317(4):30-1. PubMed ID: 8754056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
